Ketone Body Metabolism and Integrated Metabolic Homeostasis

酮体代谢和综合代谢稳态

基本信息

项目摘要

DESCRIPTION (provided by applicant): Ketone bodies are an avidly oxidized cellular fuel source, produced in abundance during the neonatal period, starvation, decompensated diabetes, and by adherence to low-carbohydrate (e.g., Atkins) diets. Ketones are known to be metabolically important for two reasons: first, their accumulation in blood can promote ketoacidosis - elicited by mismatch between rates of ketogenesis and ketone body oxidation. Second, depending on physiological state, ketones supply up to 40% of the carbon backbones that yield high-energy phosphates. While the adverse consequences of ketoacidosis are well-appreciated, experimental models to date have not revealed whether loss of ketone oxidation can be energetically tolerated. Preliminary studies from this laboratory show that germline Oxct1-/- mice, which lack the enzyme critical for ketone body utilization, succinyl-CoA:3-oxo-transferase (SCOT), are not viable after the second postnatal day. The proposed study will test the central hypothesis that ketone bodies serve an obligate energetic role in select physiological states, in that deficiencies of ketone body oxidation create metabolic abnormalities in the neonatal period and during nutrient deprivation in the adult. To specifically examine the energetic effects of ketolytic deficiency, independent of ketoacidosis, this laboratory also recently developed tissue-specific loss-of-SCOT-function mouse models that will be used within the following Specific Aims. The first aim will demonstrate the tissue- specific energetic requirement for ketone metabolism in the neonatal period. Using skeletal myocyte-, cardiac myocyte-, and neuron-specific Oxct1-/- mice, these experiments are expected to reveal the tissue(s) most dependent on ketones during the neonatal period. Next, using adult mice with loss-of-SCOT-function in skeletal muscle, collectively the largest ketone user and a key determinant of integrated metabolic homeostasis, the second aim will determine the role of ketone body metabolism in whole-body and skeletal muscle metabolism in the fed state and during prolonged nutrient deprivation. The third aim will use adult mice with loss-of-SCOT-function in heart to explore the role of ketone body metabolism in this high energy-requiring organ in the fed state and in the setting of nutrient deprivation. Because nutrient deprivation decreases glucose availability, elimination of ketone body oxidation is expected to elicit metabolic abnormalities, promote hypoglycemia, and when eliminated in cardiac muscle, contribute to the development of cardiomyopathy. Taken together, these studies will provide fundamental insight into the energetic roles of ketone body metabolism in a mammalian system, and therefore could ultimately influence (i) human newborn screening regimens, which currently do not test discrete disorders of ketone metabolism, (ii) the development of new risk- stratifying biomarkers for adult metabolic disease, and (iii) the development of individualized metabogenomics- guided nutritional regimens.
描述(由申请人提供):酮体是一种强烈氧化的细胞燃料来源,在新生儿期、饥饿、失代偿性糖尿病以及坚持低碳水化合物(例如阿特金斯)饮食期间大量产生。众所周知,酮在代谢上很重要,原因有两个:首先,它们在血液中的积累会促进酮症酸中毒——这是由生酮速率和酮体氧化速率不匹配引起的。其次,根据生理状态,酮可提供高达 40% 的碳主链,从而产生高能磷酸盐。虽然酮症酸中毒的不良后果已广为人知,但迄今为止的实验模型尚未揭示是否可以积极耐受酮氧化的丧失。该实验室的初步研究表明,种系 Oxct1-/- 小鼠缺乏对酮体利用至关重要的酶琥珀酰辅酶 A:3-氧代转移酶 (SCOT),在出生后第二天就无法存活。拟议的研究将检验一个中心假设,即酮体在特定的生理状态下发挥着强制性的能量作用,因为酮体氧化的缺陷会导致新生儿期和成人营养缺乏期间的代谢异常。为了专门检查酮解缺乏症的能量影响(独立于酮症酸中毒),该实验室最近还开发了组织特异性 SCOT 功能丧失小鼠模型,该模型将用于以下具体目标。第一个目标将证明新生儿期酮代谢的组织特异性能量需求。使用骨骼肌细胞、心肌细胞和神经元特异性 Oxct1-/- 小鼠,这些实验有望揭示新生儿期最依赖酮的组织。接下来,使用骨骼肌中 SCOT 功能丧失的成年小鼠,它们是最大的酮使用者,也是综合代谢稳态的关键决定因素,第二个目标将确定酮体代谢在全身和骨骼肌代谢中的作用在进食状态和长期营养缺乏期间。第三个目标将使用心脏 SCOT 功能丧失的成年小鼠来探索在进食状态和营养缺乏的情况下酮体代谢在这个高能量需求器官中的作用。由于营养缺乏会降低葡萄糖的利用率,因此酮体氧化的消除预计会引起代谢异常,促进低血糖,并且当在心肌中消除时,会导致心肌病的发展。总而言之,这些研究将为哺乳动物系统中酮体代谢的能量作用提供基本见解,因此可能最终影响(i)人类新生儿筛查方案,该方案目前不测试酮代谢的离散疾病,(ii)开发成人代谢疾病的新风险分层生物标志物,以及(iii)开发个体化代谢基因组学指导的营养方案。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Peter A Crawford其他文献

Peter A Crawford的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Peter A Crawford', 18)}}的其他基金

Ketogenic oscillations and neurometabolic healthspan
生酮振荡和神经代谢健康寿命
  • 批准号:
    10092796
  • 财政年份:
    2020
  • 资助金额:
    $ 35.1万
  • 项目类别:
Ketogenic oscillations and neurometabolic healthspan
生酮振荡和神经代谢健康寿命
  • 批准号:
    10646300
  • 财政年份:
    2020
  • 资助金额:
    $ 35.1万
  • 项目类别:
Ketogenic oscillations and neurometabolic healthspan
生酮振荡和神经代谢健康寿命
  • 批准号:
    10456247
  • 财政年份:
    2020
  • 资助金额:
    $ 35.1万
  • 项目类别:
Ketogenic oscillations and neurometabolic healthspan
生酮振荡和神经代谢健康寿命
  • 批准号:
    10266115
  • 财政年份:
    2020
  • 资助金额:
    $ 35.1万
  • 项目类别:
Ketogenic Oscillations and Neurometabolic Healthspan
生酮振荡和神经代谢健康寿命
  • 批准号:
    10294352
  • 财政年份:
    2020
  • 资助金额:
    $ 35.1万
  • 项目类别:
Training Program in Cardiac Innovation
心脏创新培训计划
  • 批准号:
    10666505
  • 财政年份:
    2019
  • 资助金额:
    $ 35.1万
  • 项目类别:
Training Program in Cardiac Innovation
心脏创新培训计划
  • 批准号:
    10468262
  • 财政年份:
    2019
  • 资助金额:
    $ 35.1万
  • 项目类别:
Training Program in Cardiac Innovation
心脏创新培训计划
  • 批准号:
    9792775
  • 财政年份:
    2019
  • 资助金额:
    $ 35.1万
  • 项目类别:
Training Program in Cardiac Innovation
心脏创新培训计划
  • 批准号:
    10208945
  • 财政年份:
    2019
  • 资助金额:
    $ 35.1万
  • 项目类别:
Training Program in Cardiac Innovation
心脏创新培训计划
  • 批准号:
    9922783
  • 财政年份:
    2019
  • 资助金额:
    $ 35.1万
  • 项目类别:

相似国自然基金

单核细胞产生S100A8/A9放大中性粒细胞炎症反应调控成人Still病发病及病情演变的机制研究
  • 批准号:
    82373465
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
成人型弥漫性胶质瘤患者语言功能可塑性研究
  • 批准号:
    82303926
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
  • 批准号:
    82302160
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
SERPINF1/SRSF6/B7-H3信号通路在成人B-ALL免疫逃逸中的作用及机制研究
  • 批准号:
    82300208
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于动态信息的深度学习辅助设计成人脊柱畸形手术方案的研究
  • 批准号:
    82372499
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目

相似海外基金

Preparing for a Clinical Trial in Kabuki Syndrome- Characterization of Cognitive and Neuroanatomical Features and Pilot Treatment Trial
准备歌舞伎综合症的临床试验——认知和神经解剖学特征的表征和试点治疗试验
  • 批准号:
    10220096
  • 财政年份:
    2020
  • 资助金额:
    $ 35.1万
  • 项目类别:
Preparing for a Clinical Trial in Kabuki Syndrome- Characterization of Cognitive and Neuroanatomical Features and Pilot Treatment Trial
准备歌舞伎综合症的临床试验——认知和神经解剖学特征的表征和试点治疗试验
  • 批准号:
    10661512
  • 财政年份:
    2020
  • 资助金额:
    $ 35.1万
  • 项目类别:
Preparing for a Clinical Trial in Kabuki Syndrome- Characterization of Cognitive and Neuroanatomical Features and Pilot Treatment Trial
准备歌舞伎综合症的临床试验——认知和神经解剖学特征的表征和试点治疗试验
  • 批准号:
    10438767
  • 财政年份:
    2020
  • 资助金额:
    $ 35.1万
  • 项目类别:
FGF21 activates HPA and sympathetics via neuroinflammation and plasticity
FGF21 通过神经炎症和可塑性激活 HPA 和交感神经
  • 批准号:
    8835993
  • 财政年份:
    2014
  • 资助金额:
    $ 35.1万
  • 项目类别:
Impact of Cardiovascular and Weight Loss diets on Uric Acid and Gout Risk
心血管和减肥饮食对尿酸和痛风风险的影响
  • 批准号:
    8631343
  • 财政年份:
    2013
  • 资助金额:
    $ 35.1万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了